NEW YORK (GenomeWeb News) – RTS Life Science will provide the UK Biobank with four systems for processing saliva and blood samples, the company said today.

UK Biobank, which officially launched in late July, will use four of the company’s Automated Sample Processor 800 systems to process participant samples.

The company said that the new instruments will allow the project to process up to 800 samples per day.

Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.